Notice of Results

Embargoed Release: 07:00hrs, Thursday 20th November 2008

                             SCANCELL HOLDINGS PLC                             

                         (`Scancell' or the `Company')                         

                        Notification of Interim Results                        

Scancell Holdings Plc, the developer of therapeutic cancer vaccines based on
its patented ImmunoBodyâ„¢ platform, today announces that it will release its Interim
Results for the six months ended 31 October 2008 during the week commencing
Monday 12th January 2009.

                                    -ENDS-                                     

For Further Information:

Professor Lindy Durrant         Scancell Holdings Plc    + 44 207 245 1100   
                                                                             
Adam Reynolds/Vikki Krause      Hansard Group            + 44 7515 922906    
                                                                             
Duncan Vasey/Barry Hocken       St. Helen's Capital Plc  + 44 207 628 5582